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Abstract
Background: Radon is a ubiquitous noble gas in the environment and a primary source of harmful
radiation exposure for humans; it decays in a cascade of daughters (RAD) by releasing the cell
damaging high energy alpha particles.
Results: We studied natural distribution of RAD 210Po and 210Bi in the different parts of the
postmortem brain of 86-year-old woman who had suffered from Alzheimer's disease (AD). A
distinct brain map emerged, since RAD distribution was different among the analyzed brain areas.
The highest RAD irradiation (mSv·year-1) occurred in the decreasing order of magnitude: amygdale
(Amy) >> hippocampus (Hip) > temporal lobe (Tem) ~ frontal lobe (Fro) > occipital lobe (Occ) ~
parietal lobe (Par) > substantia nigra (SN) >> locus ceruleus (LC) ~ nucleus basalis (NB); generally
more RAD accumulated in the proteins than lipids of gray and white (gray > white) brain matter.
Amy and Hip are particularly vulnerable brain structure targets to significant RAD internal radiation
damage in AD (5.98 and 1.82 mSv·year-1, respectively). Next, naturally occurring RAD radiation for
Tem and Fro, then Occ and Par, and SN was an order of magnitude higher than that in LC and NB;
the later was within RAD we observed previously in the healthy control brains.
Conclusion: Naturally occurring environmental RAD exposure may dramatically enhance AD
deterioration by selectively targeting brain areas of emotions (Amy) and memory (Hip).
Background
Alzheimer's Disease (AD), the most common cause of
dementia in the elderly, is a progressive neurodegenera-
tive disease of unknown origin that gradually robs the
patient of cognitive function and eventually causes death
[1]. Recently, we showed that radon daughters 210Po and
210Bi (RAD), accrue selectively in the brain proteins and
lipids of men and women who suffered from AD and Par-
kinson's Disease, respectively [2,3]. We proposed that AD
is a systemic brain-cell disease which selectively involves
the cell membrane protein structures of ion gates, pores,
and channels, with consequent chlorine leaking into the
cells, collapse of the cell membrane gradient, and func-
tional cell death. Other authors proposed calcium and
potassium channel impairment, respectively [4,5]; the lat-
ter authors proposed AD to be a general systemic disease
of the body as somatic fibroblasts showed the same Ca-
channel defect as that of neurons. Thus, the pathological
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substrate of AD may well be described as "channelopa-
thy", a condition where the impaired cell membrane pro-
tein structures lead to the deregulation of the ionic influx
by the brain cells [6-9].
Most of the AD studies are limited to the brain cortex and
limbic system, notably the hippocampus, since these are
the well recognized brain areas involved in the AD mem-
ory loss [10]; the role of other brain structures in AD is
poorly understood [11-13]. In this case report, we studied
the distribution of naturally occurring environmental
RAD in different brain areas in AD. Radon is a ubiquitous
noble gas in the air we breath [14], it is lipid soluble and
(in spite of being a noble gas) capable of forming weak
chemical bonds [15], and tends to accumulate in high-car-
bon body fat tissue including the brain [16]. Radon and
RAD are the source of four cell destructive high energy
alpha particles which may significantly contribute to the
internal radiation dose of the brain and play a role in AD
etiology and pathology [17,18].
Subject and methods
We studied the distribution of naturally occurring envi-
ronmental RAD polonium-210 (210Po; alpha particle
emitter) and bismuth-210 (210Bi; beta particle emitter) in
nine different brain regions of an 86-year-old deceased
woman. She was a resident of North Dakota who suffered
from AD at old age and with otherwise uneventful medi-
cal history. Post-mortem samples were obtained from all
four brain lobes, i.e., frontal (Fro). parietal (Par), occipital
(Occ), and temporal (Tem), and from the five well
defined inside the brain structures, i.e., the hippocampus
(Hip), amygdale (Amy), substantia nigra (SN), locus cer-
uleus (LC), and nucleus basalis (NB). The pathological
diagnosis of AD was based on the presence of an age-
adjusted moderate to a severe number of plaques in the
neocortex [19]. We separated cortical gray and subcortical
white matter from each brain lobe and separate gray and
adjacent white matter for every subcortical ganglion. One
gram of each sample was fractionated into protein and
lipid content before assessing 210Bi and 210Po activity sep-
arately.
Quantitative determination of the proteins and lipids
from selected brain regions and their 210Po and 210Bi radi-
oactivity was performed as described previously [2,3]. In
brief, the proteins and lipids were extracted from the gray
and white matter of the brain and ganglia by following the
respective methods of Bradford [20] and Folch et al. [21].
The protein fraction was passed through a polymembrane
under a negative pressure gradient [22]. The 210Po from
the samples and 208Po from a spiked solution were plated
on a silver disc [23]. Alpha and beta particle activities were
determined in an Alpha Spectrometer System supplied
with a radionuclide library software package (EG&G
ORTEC, Oak Ridge, TN) and a Beckman scintillation spec-
trometer (Beckman Co., Fullerton, CA), respectively.
Lead-210 (210Pb) decays to 210Bi, which in turn decays to
210Po; each decays at a different rate. After 600 days (1.64
years) a "secular equilibrium" is reached; the activities of
the 210Bi and 210Po in the sample are then equal to the
210Pb activity. The standard Bateman differential equation
of growth and decay of radio-nuclides in a decay chain
was used to correct for 210Po formation from 210Bi directly
and from 210Pb indirectly via 210Bi [24].
The radioactivity of 210Bi and 210Po was assessed in repli-
cates of every studied brain area and expressed in µBq·g-1
tissue (1 µBq equals 1 disintegration per 106 second, i.e.,
31 disintegrations per year). The difference between the
two replicates of the same sample and for the same radio-
nuclide didn't exceed 5%. We consider the difference in
the RAD radionuclide retention between any two brain
areas of >20% to be significant (>>), that of 10–20% to be
probably significant (>), and that below 10% as non-sig-
nificant (~). The normal range of the biological variability
is ± 20%, and the maximal acceptable difference between
the 210 Po and 210Bi in the same brain area sample was set
at 10%.
The particular brain area cell death radiation risk to the
high energy RAD alpha particles was calculated on the
assumption of the brain cell density of 6.4·106·g-1 (90%
glia, 10% neurons) and the average weight of the adult
female brain of 1250 g [25,26]; the brain weight of our
subject was in that category. The absorbed physical energy
was first expressed in micro Grays (µGy) and then trans-
formed to mili Sieverts (mSi) to provide for the assess-
ment of the biological effective dose of radiation [27]. It
should be noted that every single 210Po disintegration
means an instant death to a minimum of three cells along
the path of its high energy (5.305MeV) decaying alpha
particle [28]; altogether, there are four such "killing"
alpha particles in the radon decay chain (Fig 1)[15].
This research was approved by the University of North
Dakota Institutional Review Board, Grand Forks, ND
(IRB-9509-027), and carried out in full compliance with
Helsinki Declaration.
Results
The results showed a highly selective distribution of 210Po
and  210Bi in the proteins and lipids from the gray and
white matter of the brain and ganglia in AD; indeed, RAD
accumulation differs significantly between the brain areas
(Fig 2). We observed a very good congruence of 210Po and
210Bi in all the duplicate samples from the same brain
areas, indicating reliability of the results obtained by the
two different analytical methods of alpha and beta parti-Molecular Neurodegeneration 2006, 1:11 http://www.molecularneurodegeneration.com/content/1/1/11
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cle counting; values for 210Po tend to be somewhat higher
than that of 210Bi but still within the accepted limit of
accuracy. As a rule, RAD accumulation was higher in the
proteins than lipids of various brain structures, and higher
in the gray than white brain matter proteins, respectively.
The retention of RAD in the gray brain matter proteins
was, in the decreasing order of magnitude:
Hip >> Amy >> Tem ~ Fro > Occ ~ Par > SN >> LC ~ NB.
 (A)
RAD retention was generally lower in the white matter
brain and cerebral ganglia proteins than that of the gray
brain matter. The comparable sequence for both RAD
(210Po and 210Bi) in the white brain matter proteins was
somewhat different from that in the grey matter:
Tem > Fro>> Occ ~ Par ~ Hip >> SN > Amy >> LC ~ NB
(B)
It should be noted that the range of the 210Po activity in
the gray matter proteins of the different brain structures
(A) may be as low as 150 µBq for NB and as high as 2906
µBq in the Hip [or 100 vs. 2138 µBq (per gram) of 210Bi
for the same brain structures], a factor of 20 difference! A
similar range was also observed in the proteins from the
brain white matter (B), although the actual sequence was
somewhat different (50 vs. 1152 µBq·g-1of 210Po and 50
vs. 1119 µBq·g-1of 210Bi for NB and Tem, respectively).
The notable exception to the uniformly higher RAD accu-
mulation in the gray (A) and white (B) brain matter pro-
teins than lipids in AD was the accentuated RAD retention
in the amygdale lipids. Indeed, the retention of 210Po and
210Bi in the Amy lipids reached astonishing 9285 and
6162 µBq·g-1, respectively, well above anything we have
observed of RAD in any other brain area. The retention of
468 µBq·g-1 of 210Po and 362 µBq·g-1 of 210Bi in the Hip
was the next highest for the RAD retention in the lipids.
Although increased in relation to the other lipid RAD, the
Hip lipid RAD retention was at the lower end of the RAD
activities seen in the proteins.
To better assess the radiation risk from 210Po "killer" alpha
particles over the last year of the subject's life, we com-
bined together 210Po activity in the gray brain matter pro-
teins and lipids, since proteins and lipids from the same
anatomical structure are not naturally separated. Appar-
ently, a substantial brain cell loss should have occurred in
the Amy and Hip as a result of the cell killing potential of
the high energy RAD alpha particles (Table 1) [29]. The
decreasing order of magnitude sequence of RAD 210Po in
proteins and lipids from different brain areas showed the
radiation risk to be:
Amy >> Hip > Tem ~ Fro > Occ ~ Par > SN >> LC ~ NB
(C)
We estimated that a minimum of 15% of amygdale cell
population per gram tissue (>106 cells) was destroyed
over a single year, about 5% of hippocampus cell popula-
tion was also destroyed over the same time, and as much
as 1–2% of that in the four brain lobe cell population.
Since the brain lobes have a total cell mass considerably
greater than that of Amy and Hip, the actual cell loss from
Radon (222Rn) radiation decay Figure 1
Radon (222Rn) radiation decay.Molecular Neurodegeneration 2006, 1:11 http://www.molecularneurodegeneration.com/content/1/1/11
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brain lobes would be also substantial. Evidently, the dif-
ferent areas of the AD brain are exposed to a different radi-
ation risk and consequent cell loss.
Discussion
The major finding of this case report is that the explored
areas of the AD brain are specifically and selectively tar-
geted by RAD, so that there is a different radiation risk to
the various brain structures at the same environmental
radon and RAD exposure. It has never before been
observed that naturally occurring environmental RAD can
reach dangerous levels of radiation exposure in certain
brain areas such as Amy and Hip. These findings also con-
firmed our previous observations about brain proteins as
a targeted biochemical compartment in the AD brain.
Indeed, the RAD deposition in the gray and white brain
matter proteins and lipids from the frontal and temporal
brain lobes of this single subject were within the average
values we reported for the same brain structures in a group
of people who suffered from AD (see Table 1) [2,3]. Con-
sequently, if the RAD deposition to the proteins and lipids
of the two identical brain regions in these two separate
studies is approximately equal, it is reasonable to assume
that RAD distribution in all the other areas of the AD
brain would also have the same pattern of distribution as
found here. North Dakota is known for it's high RAD [31],
but the RAD in the frontal and temporal region of this
case is very well within the average RAD from the same
brain region samples obtained from the Alzheimer's
Foundation [2,3]. Since the Alzheimer's Foundation
brains came from the different parts of the USA, it appears
that, according to our instrument limits, the regional envi-
ronmental exposure to RAD did not affect the RAD brain
distribution.
Brain structure distribution of polonium-210 () and bismuth-210 (■ ) in the proteins and lipids of the gray and white brain  matter in an Alzheimer disease victim (µBq g-1 tissue) Figure 2
Brain structure distribution of polonium-210 () and bismuth-210 (■ ) in the proteins and lipids of the gray and white brain 
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Our study identified the proteins in the hippocampus and
amygdale as a two primary brain area targets for RAD in
AD. Further, we noted that there was two times more RAD
deposited in hippocampus than in the cortex per unit
mass of the protein. This is an indicative ratio since the
Hip is assembled of three cellular layers identical with
three out of six cell layers of the brain cortex [25]. Thus, if
three Hip layers yield two times more RAD than the six
layers of the brain cortex, and three of the cortex layers are
identical with those of Hip, it is evident that the presence
of three more (but different) cortical layers did not con-
tributed to the RAD; therefore we think that our finding
supports the concept of laminar specificity of cortical
pathology in AD [10] We also noted biochemical similar-
ity of RAD retention in the parietal and occipital lobe pro-
teins vs. that in respective frontal and temporal lobes; the
later was higher (C).
The lowest RAD retention was observed in the proteins of
locus ceruleus and nucleus basalis, otherwise an area
where a great neuronal loss was reported for LC, NB, and
SN in AD subjects [13,31]. Since neurons are also com-
posed of proteins, this observation implies how proteins
from these brain areas may have either different affinity
for RAD or, perhaps, the fact that we analyzed proteins in
both neurons and glia cells of the brain; the later is much
more abundant (90%). Events like impaired conforma-
tional changes in protein post-synaptic scaffolding [32],
the fall in number of neuron synaptic contacts [33] the
failing support of astrocytes which are especially vulnera-
ble to the ionic radiation [34], and cyto-architectonic col-
lapse of functional neurons [35], may all precede the
neuronal loss in AD brain.
We predicted correctly that, as in the previous AD study,
RAD would as well selectively accrue in the brain cell pro-
teins of Amy and Hip [2,3]; what we didn't know at that
time was that different brain areas would had quite dis-
tinct RAD affinity. Essentially, our finding of high protein
RAD affinity in AD credits the importance of mal variant
AD proteins in the neurons [6-8], with a caveat that actual
mal variant protein biochemical structure may be quite
different for various brain areas and their cell population.
The reason for the repeatedly observed high RAD protein
affinity and respective brain area specific protein affinity
in AD remains obscure. We only know that the biochem-
ical structure of the AD protein could be changed such
that more carbon bonds would be available to moderate
radon movement before radon decays in RAD; it may be
even some variety of a prion protein of a chronic disease
[9]. It has been shown that metals Al, Cu, Fe, Pb, Si, and
Zn acts like a potent "seeding" factors inducing excessive
amyloid Aβ peptide formation [36-39]. Indeed, Aβ is a
major protein component of the senile plaque and what
is the hallmark of AD [40]; the degradation of these excess
proteins in the AD brain is further reduced by the lack of
the proteosomes, a large protein complex responsible for
intracellular degradation of misfolded, oxidized, or aggre-
gated proteins [41]. Since radon is a radioactive noble gas
it transfers freely across the blood-brain barrier in and out
of the brain; when radon decays to RAD both the high
energy of cell killing potential is released and the heavy
metals generated, the later would act as a potent seeding
agents for Aβ generation. Thus, radon can be both a direct
cause of AD via the imunogenic debris of the killed cells
of already changed proteins in the AD brain, and by also
enhancing Aβ synthesis.
The only exception to the rule that AD specifically targets
the brain matter proteins was that in this subject the high-
est RAD deposition was observed in the amygdale gray
matter lipids. Since we already saw selective RAD accumu-
lation to the brain lipids in Parkinson's disease [2,3], we
concluded that an unfortunate event had occurred to this
study's subject. i.e., the combined protein and lipid cell
membrane chanellopathy. This failure of AD brain cell
Table 1: Estimated annual regional brain cell loss and cell dose per gram tissue from 210Po high energy alpha particles (5.305 MeV) in 
the proteins and lipids.*
Brain structure Emissions Estimated cell loss Cell dosimetry Energy absorbed Biolgical effectiveness
Bq•y•g-1 Number %•y-1 βGy•yr-1 mSv•y-1
Amygdale 347 828 1 043 484 16.65 295 5.90
Hippocampus 106 475 319 426 4.99 90 1.80
Temporal lobe 50 078 150 233 2.35 42 0.85 0.79a
Frontal lobe 49 545 148 635 2.32 42 0.84 0.75a
Occipital lobe 43 739 131 217 2.05 37 0.74
Parietal lobe 39 005 117 016 1.83 33 0.66
Substantia nigra 30 855 92 564 1.45 27 0.54
Locus ceruleus 6 848 20 544 0.30 6 0.12
Nucleus basalis 6 848 20 544 0.30 6 0.12
*The average person absorbs ≈450 βGy of cosmic radiation in a year. Since all 210Po radiation is composed solely of alpha particles then a relative 
effective factor is 20 (1 Sv = 20 Gy) [29].
aMomčilović et al.[2,3].Molecular Neurodegeneration 2006, 1:11 http://www.molecularneurodegeneration.com/content/1/1/11
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lipids may be secondary to the failures of protein folding,
their conformation change, appearance of false ionic
channels, and consequent failure in the Ca-channel ionic
cell influx [3,42,43].
We are impressed that the tiny amygdale alone received an
equivalent of 2/3 of the respective total yearly human
body physical energy dose from cosmic rays (299 vs. 450
µG·y-1) [29]. The biological quality of different types of
radiation is different (alpha being the most adverse to the
biological tissue), and when the results are corrected for
the high biological quality factor of alpha radiation, Amy
will receive a fifteen-times greater biological effective radi-
ation dose than the whole human body over the entire
year (5980 vs. 450 µSi·y-1, respectively). Approximately
one million of Amy cells will be killed in a year, an equiv-
alent of one gram of that 10 gram heavy brain structure.
This estimate is a very conservative approximation, based
on only three direct cell kills per decayed high energy
alpha particle, since as much as fifty cells may be irrepara-
bly injured and die after some delay by a single 210Po
alpha particle as a result of the "bystander effect" [44].
What we observed in this AD brain is the internal radia-
tion "amygdalectomy" and how that might explain some
of the respective emotional torpidity and insensitivity
associated with AD and old age. This case appears to fit the
usual pattern of events in AD; on average, person spend
several years in the mild or minimal stages, between 4 and
5 years in the moderate disease stages, and depending on
the quality of care in the depending stages, a year or more
requiring full nursing care [45].
Conclusion
In conclusion, AD is a complex and progressive brain dis-
ease characterized by the failing ability to cope with envi-
ronmental xenobiotic hazards [2,3], excessive free radical
injury, inflammation and immunity deficiency [46], cell
repair impairment [47], and the protein synthesis [48].
The ubiquitous environmental RAD exposure, and high
RAD accumulation in the sensitive brain structures may
either induce or hasten or both the irreversible "shut
down" process of the ailing human brain in AD.
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